ConductScience.org, home

Paper18367671

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.

Wilkinson SR and 4 others. Proc Natl Acad Sci U S A, 2008. Cited by 357 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Papers, record 18367671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18367671

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
357
iCite
Relative citation ratio, by iCite
11
iCite
Revised in PubMed
2024-06-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilkinson SRShane R
2Taylor MCMartin C
3Horn DDavid
4Kelly JMJohn M
5Cheeseman IIan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug ResistanceMajor topic
NifurtimoxMajor topic
NitroimidazolesMajor topic
Trypanocidal AgentsMajor topic
Trypanosoma cruziMajor topic
Animals
Gene Expression Regulation
Genome, Protozoan
Mitochondria
Nitroreductases
Phenotype
Protozoan Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19952319Enzymatic reduction studies of nitroheterocycles.Biochem Pharmacol1999https://conductscience.org/library/papers/9952319PubMed
216559085Mode of action of nitrofurazone.J Bacteriol1970https://conductscience.org/library/papers/16559085PubMed
39377478A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata.Biol Chem1997https://conductscience.org/library/papers/9377478PubMed
42406032Sensitivity of parasites to free radical damage by antiparasitic drugs.Chem Biol Interact1990https://conductscience.org/library/papers/2406032PubMed
58259135Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages.Mol Biochem Parasitol1993https://conductscience.org/library/papers/8259135PubMed
612417633A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi.J Exp Med2002https://conductscience.org/library/papers/12417633PubMed
712811546Nitroheterocyclic drugs with broad spectrum activity.Parasitol Res2003https://conductscience.org/library/papers/12811546PubMed
83247312Evidence for the involvement of a nitrenium ion in the covalent binding of nitrofurazone to DNA.Pharm Res1988https://conductscience.org/library/papers/3247312PubMed
94941089Breakage of bacterial DNA by nitrofuran derivatives.Cancer Res1971https://conductscience.org/library/papers/4941089PubMed
1017145786Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17145786PubMed
1116413403Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei.Free Radic Biol Med2006https://conductscience.org/library/papers/16413403PubMed
1217446142Discovery of ubiquinone (coenzyme Q) and an overview of function.Mitochondrion2007https://conductscience.org/library/papers/17446142PubMed
133130683Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.Trans R Soc Trop Med Hyg1987https://conductscience.org/library/papers/3130683PubMed
149662705Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.Mol Biochem Parasitol1998https://conductscience.org/library/papers/9662705PubMed
1516182389Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects.Mol Biochem Parasitol2005https://conductscience.org/library/papers/16182389PubMed
1611020276Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: a prodrug-activating enzyme.J Med Chem2000https://conductscience.org/library/papers/11020276PubMed
176327675Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase.J Biol Chem1984https://conductscience.org/library/papers/6327675PubMed
18338576Genetics of nitrofurazone resistance in Escherichia coli.J Bacteriol1978https://conductscience.org/library/papers/338576PubMed
1916756485Energy converting NADH:quinone oxidoreductase (complex I).Annu Rev Biochem2006https://conductscience.org/library/papers/16756485PubMed
202614608Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.J Parasitol1989https://conductscience.org/library/papers/2614608PubMed

See all 42 referencesDownload CSV of references

Cited by218

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 357 citations.

PMIDTitleJournalYearIn PapersSource
42603444Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay.Int J Parasitol Drugs Drug Resist2026https://conductscience.org/library/papers/42603444PubMed
42454824Advances and challenges in the search for new treatments for Chagas disease.Mem Inst Oswaldo Cruz2026https://conductscience.org/library/papers/42454824PubMed
42401745A cell surface transporter mediates phenanthridine resistance in African trypanosomes.NPJ Antimicrob Resist2026https://conductscience.org/library/papers/42401745PubMed
42371586Pathogenic Significance of Trypanosomatids: Progress in Drug Resistance, Control Strategies, and Artificial Intelligence.Interdiscip Perspect Infect Dis2026https://conductscience.org/library/papers/42371586PubMed
42358646Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.J Pharm Pharm Sci2026https://conductscience.org/library/papers/42358646PubMed
42307013Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part III.ACS Infect Dis2026https://conductscience.org/library/papers/42307013PubMed
42221541Trypanosomatid parasites, translational research in a One Health, One World environment.Front Chem2026https://conductscience.org/library/papers/42221541PubMed
42108536A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate.J Antimicrob Chemother2026https://conductscience.org/library/papers/42108536PubMed
42062475Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination.NPJ Antimicrob Resist2026https://conductscience.org/library/papers/42062475PubMed
41932358Targeting Kinetoplastid Parasites with ProTide Prodrugs: A Proof-of-Concept Study.ChemMedChem2026https://conductscience.org/library/papers/41932358PubMed
41599779Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41599779PubMed
41394106Differential antioxidant enzyme profiles reveal early molecular signatures of virulence in Trypanosoma cruzi DTU-TcI and DTU-TcVI strains.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41394106PubMed
41355869Synthesis and evaluation of nitroheterocyclic aromatic adamantane amides with trypanocidal activity. Part II.RSC Med Chem2026https://conductscience.org/library/papers/41355869PubMed
41182628A Single-Cell Methodology for Energy Metabolism Analysis in Parasitic Protozoa.Methods Mol Biol2026https://conductscience.org/library/papers/41182628PubMed
41134857Fexinidazole results in specific effects on DNA synthesis and DNA damage in the African trypanosome.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/41134857PubMed
41011282Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41011282PubMed
40941913Buddleja globosa Leaf Methanolic Extract Acts Against Trypanosoma cruzi Parasites by Inducing Mitochondrial Inner Membrane Hyperpolarization.Plants (Basel)2025https://conductscience.org/library/papers/40941913PubMed
40934206Glycosomal ABC transporter 3 (GAT3) deletion enhances the oxidative stress responses and reduces the infectivity of Trypanosoma cruzi.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/40934206PubMed
40863176Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against Trypanosoma cruzi and Leishmania mexicana.Metabolites2025https://conductscience.org/library/papers/40863176PubMed
40781240Lipid-mediated gating of a miniature mechanosensitive MscS channel from Trypanosoma cruzi.Nat Commun2025https://conductscience.org/library/papers/40781240PubMed

See all 218 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18367671

GET https://conductscience.org/api/papers/v1/18367671/references?page=2